These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6982169)

  • 1. Decreased central serotonin function in hypothyroidism.
    Vaccari A
    Eur J Pharmacol; 1982 Aug; 82(1-2):93-5. PubMed ID: 6982169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of neonatal dysthyroidism on serotonin type 1 and type 2 receptors in rat brain.
    Vaccari A; Biassoni R; Timiras PS
    Eur J Pharmacol; 1983 Nov; 95(1-2):53-63. PubMed ID: 6667715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral evidence for denervation supersensitivity after destruction of central serotonergic nerve terminals.
    Trulson ME; Jacobs BL
    Ann N Y Acad Sci; 1978 Jun; 305():497-509. PubMed ID: 309301
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
    Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of triiodothyronine (T3) on the potentiation by antidepressants of L-5-hydroxytryptophan-induced head-twitches in mice.
    Martin P; Massol J; Soubrie P; Puech AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(5):735-48. PubMed ID: 2789414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitive serotonergic receptors: a new hypothesis for one subgroup of unipolar depression derived from an animal model.
    Aprison MH; Hingtgen JN
    Adv Exp Med Biol; 1981; 133():627-56. PubMed ID: 6976074
    [No Abstract]   [Full Text] [Related]  

  • 7. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine.
    Trulson ME; Eubanks EE; Jacobs BL
    J Pharmacol Exp Ther; 1976 Jul; 198(1):23-32. PubMed ID: 132525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to high pressure may produce the 5-HT behavioral syndrome in rats.
    Wardley-Smith B; Hudson S; Doré CJ; Charlett A; Fletcher A; Brammer NT; Minchin MC; Wann KT
    Undersea Biomed Res; 1990 Jul; 17(4):275-86. PubMed ID: 1697708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ergot drugs on serotonergic function: behavior and neurochemistry.
    Silbergeld EK; Hruska RE
    Eur J Pharmacol; 1979 Sep; 58(1):1-10. PubMed ID: 315322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged deficits in presynaptic serotonin function following withdrawal from chronic cocaine exposure as revealed by 5-HTP-induced head-twitch response in mice.
    Darmani NA; Shaddy J; Elder EL
    J Neural Transm (Vienna); 1997; 104(11-12):1229-47. PubMed ID: 9503268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothyroidism Induces Hypophagia Associated with Alterations in Protein Expression of Neuropeptide Y and Proopiomelanocortin in the Arcuate Nucleus, Independently of Hypothalamic Nuclei-Specific Changes in Leptin Signaling.
    Calvino C; Império GE; Wilieman M; Costa-E-Sousa RH; Souza LL; Trevenzoli IH; Pazos-Moura CC
    Thyroid; 2016 Jan; 26(1):134-43. PubMed ID: 26538454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amitriptyline sensitization of a serotonin-mediated behavior depends on the passage of time and not repeated treatment.
    Antelman SM; DeGiovanni LA; Kocan D; Perel JM; Chiodo LA
    Life Sci; 1983 Oct; 33(17):1727-30. PubMed ID: 6605468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of serotonin in development of morphine dependence in mice and rats.
    Kruszewska A
    Pol J Pharmacol Pharm; 1980; 32(5):655-63. PubMed ID: 6973754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a tryptophan-free diet on prolactin and corticosterone release by serotonergic stimuli.
    Clemens JA; Bennett DR; Fuller RW
    Horm Metab Res; 1980 Jan; 12(1):35-8. PubMed ID: 6965657
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of serotonergic agents in the clinical assessment of central serotonin function.
    Murphy DL; Mueller EA; Garrick NA; Aulakh CS
    J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxepin as a blocker of central serotonin receptors.
    Maj J; Gancarczyk L; Górszczyk L; Rawłów A
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Dec; 10(6):318-24. PubMed ID: 309138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological effects of oxaprotiline enantiomers on the central serotonin system.
    Maj J; Dereń A; Moryl E
    Pol J Pharmacol Pharm; 1989; 41(4):345-57. PubMed ID: 2534522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal cord injury-specific depression of monosynaptic spinal reflex transmission by l-5-hydroxytryptophan results from loss of the 5-HT uptake system and not 5-HT receptor supersensitivity.
    Honda M; Tanabe M; Ono H
    Exp Neurol; 2006 Nov; 202(1):258-61. PubMed ID: 16806182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral correlates of serotonin depletion.
    Harvey JA; Schlosberg AJ; Yunger LM
    Fed Proc; 1975 Aug; 34(9):1796-801. PubMed ID: 125207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.